Sarepta Therapeutics was awarded a voucher for a fast-track drug review by the Food and Drug Administration when the company's medicine for Duchenne muscular dystropy was approved Sept. 19. Now Sarepta is looking to sell the voucher to the highest bidder.
Mick Wiggins/Ikon Images/Getty Images
NPR's Wei Quan holds a sign prompting people to respond to the #DearWashington social media conversation about what issues the next president should know about this election season.
Bob Topmiller, chief of toxicology at the Hamilton County Coroner's Office, holds a small vial containing carfentanil extracted from a sample of blood.
Jake Harper/Side Effects Public Media
Dr. Lars Aanning, seen at his home outside Yankton, S.D., said he lied to protect a colleague in a malpractice case. Now, Aanning is a patient safety advocate.
Jay Pickthorn/AP for ProPublica
Heather Bresch, CEO of Mylan Pharmacueticals, will face lawmakers' questions Wednesday about the company's steep price hikes for the company's life-saving EpiPen auto-injector.